Halozyme Therapeutics Inc (HALO)

[stockrafter]

Heads up for Fred....a post on ATRS stuff to ignore....

Since the lazy IR department won't post the info....

Halozyme is moving on a few of ATRS legacy drugs.

New hydrocortisone patent filed, and possible trademarks names posted, getting ready for late 2023 launch.

ATRS-Halo products

1. ATRS-1901 —— VARENICLINE PRODRUGS … https://www.freepatentsonline.com/WO2022147189A1.html

2. ATRS -1902 —— hydrocortisone — Adrenal Insufficiency…launch by end of 2023.. https://www.freepatentsonline.com/y2023/0099165.html

3. ATRS-1903 —— Immunology… “emergency use rescue pen to be used in acute immunologic mediated reactions.”

4. ARTS-2002 — abiraterone acetate…sitting in clinical trial for years……

5. Naxredy —— Naloxone …surprise move….takes over Naxredy trademark after Pfizer abandoned it…

Partnered ATRS related products

1. Pfizer…..now that Naxredy has been transferred to ATRS ……this leaves a hole in the Pfizer/ATRS AI deal…which makes XXX much likely candidate…..and grearing up for launch in 2024….not a big drug, only estimated at $230 mill/yr....it will last for years to come....

2. Idorsia….. Selatogrel….possible launch in 2024.....again not a billion/yr product but it will provide income for years to come.....

Now onto the Halozyme drugs....whew what a list........much harder.....